Moderna Stock News

Gricd, a cold chain technology company that uses the Internet of Things to enable last-mile delivery of temperature-sensitive products, has teamed up with Nigerias National Primary Health Care Development Agency (NPHCDA) to deliver 4.2 million doses of the Moderna COVID-19 vaccine to all 36 states of the country and the Federal Capital Territory. This batch of the Moderna vaccines was donated by USAID to the Nigerian government through the COVAX initiative and required storage conditions between -15 degrees and -25 degrees Celsius. Continue reading Gricd, NPHCDA to Deliver 4.2M Doses of Moderna COVID-19 Vaccines at BizWatchNigeria.Ng.

The study at the University of Oxford in the UK found that no safety concerns were raised in the study of 1,070 participants

600 Fines: What''s The Latest On Austria''s Compulsory Vaccine Plan? By The Local Austria''s planned vaccine mandate law will take a step towards becoming reality this week, and will reportedly apply from the age of 14, with fines of 600 which can be issued multiple times. Several of Austrias major national newspapers including the Kurier , Die Presse, Heute and Der Standard claimed to have seen a copy of the draft law, though the Ministry of Health declined to comment on it when asked by broadcaster ORF , saying an official first draft will be submitted later this week. According to the media reports, the law will come into effect on February 1st but fines will not be issued until March 15th, allowing people the chance to get vaccinated after the law becomes reality. The government has however repeatedly urged Austrian residents not to wait until the mandate to get their jab. Reminder letters inviting people to vaccination would be sent by the Ministry of Health in February; similar letters have already been sent out by social insurance agencies.

The immune response in people who received the first dose of COVID-19 vaccines from Astra Zeneca and Biontech / Pfizer with Moderna was higher, according to a large British study. "We found a really good immune response overall actually higher than the threshold set by the two doses of Astra Zeneca vaccine," Matthew Snape, an Oxford professor who led a study called Com-COV2, told Reuters. If the Astra Zeneca vaccine is followed by the Moderna or Novavax vaccine, the number of antibodies and T cells is higher than with two doses of Astra Zeneca, the researchers found. The study, which involved 1,070 volunteers, also showed that one dose of the Biontech / Pfizer vaccine was followed by Moderna or Novavax. The results are good news, especially for lower-income countries that cannot afford a broad enough portfolio of vaccines, Reuters added. /Dnevnik

Researchers have found that switching up vaccines for the second dose can lead to a strong immune response, especially a shot of AstraZeneca or Pfizer followed by Moderna. This may be good news for countries adopting a mix and match strategy for primary immunizations. Eve Johnson reports.

Which combination of COVID vaccines is better at protecting against coronavirus? Various combinations of coronavirus vaccines increase the bodys immune response to coronavirus. AstraZeneca and Moderna or Novavax coronavirus vaccine combinations produce much higher levels of neutralizing antibodies and T cells than the Swedish-British mono vaccine. Scientists looked at the data of 1,070 British people [] The post Experts find the best combination of vaccines to protect against COVID-19 appeared first on Revyuh .

Combination of 1st dose of the AstraZeneca vaccine with the 2nd dose of either the Moderna or Novavax produces greater levels of antibodies, claimed new study.

A major British study into mixing Covid-19 vaccines found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine weeks later.

A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine weeks later, according to the results on Monday. We found a really good immune response across the board, in fact, higher than the threshold []

Dec 6 (Reuters) - A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine weeks later, according to the results on Monday.

Brokerages forecast that Moderna, Inc. (NASDAQ:MRNA) will report earnings of $8.44 per share for the current quarter, according to Zacks Investment Research. Six analysts have issued estimates for Modernas earnings. The lowest EPS estimate is $5.25 and the highest is $10.27. Moderna reported earnings of ($0.69) per share in the same quarter last year, which []

https://www.investing.com/news/stock-market-news/mixing-pfizer-astraz-covid19-shots-with-moderna-gives-better-immune-response--uk-study-2701918

A first dose of AstraZeneca followed by a second dose of Moderna or Novavax induces more antibodies and T-cells than two AstraZeneca injections, Oxford University researchers found.

Study participants who received a first dose of either jab generated a robust immune response when given a second dose of Novavax or Moderna.

Moderna president said current COVID-19 vaccines probably aren''t effective against the new variant.